Advertisement

The Clinical Consultative Role of the Blood Bank in Transfusion Medicine

  • C. Th. Smit Sibinga
Chapter
Part of the Developments in Hematology and Immunology book series (DIHI, volume 31)

Abstract

In 1991 during one of the consultations organized by the WHO Global Blood Safety Initiative [1], a working definition of Transfusion Medicine was composed and defined in consensus to facilitate communication, evaluation and exchange of information and expertise. The definition reads:
  • ‘Transfusion Medicine deals with that part of the Health Care System which undertakes the appropriate provision and use of human blood resources.’

  • Transfusion Medicine thereby provides the essential scientific and clinical information for transfusion practice and the link between the altruistic blood donor and the patient.

Keywords

Transfusion Medicine Good Manufacture Practice Transfusion Practice Decision Taking Transfusion Policy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Report of the GBSI informal consultation on Collaboration in Training in Transfusion Medicine. Geneva WHO/LBS/92.7.Google Scholar
  2. 2.
    Consensus Conference: Fresh frozen plasma: Indications and risks. JAMA 1985;253: 551–53.CrossRefGoogle Scholar
  3. 3.
    Consensus Conference: Platelet transfusion therapy. JAMA 1985;257:1777–80.Google Scholar
  4. 4.
    Consensus Conference: Leucocyte depletion of blood and blood components. The Royal College of Physicians of Edinburgh, Edinburgh 1993.Google Scholar
  5. 5.
    Consensus statement on red cell transfusion. Trans Med 1994;4:177–78.Google Scholar
  6. 6.
    Quality assurance in blood banking and its clinical impact. Smit Sibinga CTh, Das PC, Tas well HF (eds). Martinus Nijhoff Publ., Boston, The Hague, Dordrecht, Lancaster, 1984.Google Scholar
  7. 7.
    The rules governing medicinal products in the European community. Vol IV. Guide to Good Manufacturing Practice for Medicinal Products. ECSC-EEC-EAEC, 1989.Google Scholar
  8. 8.
    Zuck TF. The Good Manufacturing Practice concept. In: Smit Sibinga CTh, Das PC, Heiniger HJ (eds). Good Manufacturing Practice in Transfusion Medicine. Kluwer Acad. Publ., Dordrecht, Boston, London, 1994:25–34.CrossRefGoogle Scholar
  9. 9.
    Bordin JO, Heddle NM, Blajchman MA. The biologic effect of leukocytes present in transfused cellular blood products. Blood 1994;84:1703–21.PubMedGoogle Scholar
  10. 10.
    Supportive therapy in haematology. Das, Smit Sibinga CTh, Halie MR (eds). Martinus Nijhoff Publ., Boston, Dordrecht, Lancaster, 1985.Google Scholar
  11. 11.
    Murphy WG. Factors effecting the clinical efficacy of blood transfusion. In: Smit Sibinga CTh, Das PC, Snijder EL (eds). Trigger factors in transfusion medicine. Kluwer Acad. Publ., Boston, Dordrecht, London, 1996:65–72.Google Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • C. Th. Smit Sibinga

There are no affiliations available

Personalised recommendations